Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors
Clinical trial NCT05038839 · COMPLETED
Trial details
- NCT number
- NCT05038839
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-09
- Primary completion
- 2026-05-05
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.